Astrazeneca Pharma India falls; Sebi says exchanges to monitor delisting

Tags: Companies
Shares in Astrazeneca Pharma India Ltd fell 3 percent after the SEBI on Tuesday said stock exchanges will closely monitor the company's delisting process and promptly report any aberrations.

"The promoters of M/s Astrazeneca Pharma India Ltd. shall finally purchase shares from public shareholders in the delisting offer only after seeking approval of the Bombay Stock Exchange Limited and National Stock Exchange Limited," added the Securities and Exchange Board of India in an order.

The regulator also said it came across certain reports that the offer for sale (OFS) of the shares of Astrazeneca Pharma India Ltd carried out by its promoter AstraZeneca Pharmaceuticals AB Sweden on May 26, 2013 was a deliberate attempt to subsequently get the shares of the Indian unit delisted at ease.

It was also reported that more than 94 percent of total shares offered through OFS had been subscribed by six foreign institutional investors including DB International Asia Ltd, Suffolk (Mauritius), Morgan Stanley Asia (Singapore) PTE, BNP Paribas Arbitrage, Manfield (Mauritius) Ltd and Merrill Lynch Capital Markets Espana S.A. SVB.

EDITORIAL OF THE DAY

  • Presdential election may have become a battle field, but the final call rests with Modi

    Forging a national consensus on the presidential candidate should be the best option for both ruling National Democratic Alliance (NDA) led by prime m

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Sandeep Bamzai

Freedom Files : Creating a communal cleave

The Nawab of Bhopal Sir Hafiz Hamidullah Khan, saboteur ...

Susan Visvanathan

Landed in trouble

The British always required get away places. Shimla is the ...

Kuruvilla Pandikattu

How to understand each other better

How do we understand and encounter people? But how can ...